Download presentation
Presentation is loading. Please wait.
Published byVeronica Allen Modified over 5 years ago
1
The Journal of Allergy and Clinical Immunology: In Practice
Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study Luis A. Pérez de Llano, MD, PhD, Borja G. Cosío, MD, PhD, Christian Domingo, MD, PhD, Isabel Urrutia, MD, PhD, Irina Bobolea, MD, PhD, Antonio Valero, MD, PhD, Luis M. Entrenas Costa, MD, PhD, Santiago Quirce, MD, PhD, Pilar Barranco, MD, PhD, Nuria Marina Malanda, MD, Luis Prieto Andrés, MD, PhD, Francisco J. Alvarez-Gutiérrez The Journal of Allergy and Clinical Immunology: In Practice DOI: /j.jaip Copyright © 2019 The Authors Terms and Conditions
2
Figure 1 Flowchart diagram of the study.
The Journal of Allergy and Clinical Immunology: In Practice DOI: ( /j.jaip ) Copyright © 2019 The Authors Terms and Conditions
3
Figure 2 Changes in asthma outcomes over the study period. A, Changes in ACT score over the 24-week study period. B, Changes in 7-item ACQ (ACQ-7) score. C, Changes in AQLQ score. D, Changes in FEV1. AQLQ, Asthma Quality of Life Questionnaire. The Journal of Allergy and Clinical Immunology: In Practice DOI: ( /j.jaip ) Copyright © 2019 The Authors Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.